Skip to main content
. 2018 Sep 19;9:2105. doi: 10.3389/fimmu.2018.02105

Figure 3.

Figure 3

Lymphoma-associated CARD11 mutations. Mutations are depicted that have been validated to have at least a 3-fold increase in CARD11 signaling in a quantitative signaling assay. ABC, Activated B Cell-like; DLBCL, Diffuse Large B Cell Lymphoma; GCB, Germinal Center B cell; MCL, Mantle Cell Lymphoma; PCNSL, Primary Central Nervous System Lymphoma; ATLL, Acute T cell Leukemia/Lymphoma; TFH, Follicular T helper; PTCL, Peripheral T cell Lymphoma.